GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hunan Dajiaweikang Pharmaceutical Industry Co Ltd (SZSE:301126) » Definitions » YoY Rev. per Sh. Growth

Hunan Dajiaweikang Pharmaceutical Industry Co (SZSE:301126) YoY Rev. per Sh. Growth : 47.71% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hunan Dajiaweikang Pharmaceutical Industry Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Hunan Dajiaweikang Pharmaceutical Industry Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was 47.71%.

Hunan Dajiaweikang Pharmaceutical Industry Co's Revenue per Share for the three months ended in Mar. 2024 was ¥5.93.


Hunan Dajiaweikang Pharmaceutical Industry Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for Hunan Dajiaweikang Pharmaceutical Industry Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Dajiaweikang Pharmaceutical Industry Co YoY Rev. per Sh. Growth Chart

Hunan Dajiaweikang Pharmaceutical Industry Co Annual Data
Trend Dec12 Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.47 -5.15 10.27 -3.56 20.06

Hunan Dajiaweikang Pharmaceutical Industry Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.20 19.43 29.69 4.74 47.71

Hunan Dajiaweikang Pharmaceutical Industry Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Hunan Dajiaweikang Pharmaceutical Industry Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(19.347-16.114)/ | 16.114 |
=20.06 %

Hunan Dajiaweikang Pharmaceutical Industry Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=(Revenue per Share (Q: Mar. 2024 )-Revenue per Share (Q: Mar. 2023 )) / | Revenue per Share (Q: Mar. 2023 )) |
=(5.929-4.014)/ | 4.014 |
=47.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Dajiaweikang Pharmaceutical Industry Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Hunan Dajiaweikang Pharmaceutical Industry Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Dajiaweikang Pharmaceutical Industry Co (SZSE:301126) Business Description

Traded in Other Exchanges
N/A
Address
No. 30 Fuling Road, Yuelu District, Hunan Province, Changsha, CHN, 410000
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is engaged in the distribution and retail of pharmaceuticals, biological products, medical equipment and other products.
Executives
Tang Juan Supervisors
Zhong Xue Song Director

Hunan Dajiaweikang Pharmaceutical Industry Co (SZSE:301126) Headlines

No Headlines